e-learning
resources
Munich 2014
Monday, 08.09.2014
Healthcare, prevention and adjunctive treatments in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary fungal infection in immunocompetent vs immunocompromised patients - a retrospective study
A. Silva, R. Tomé, M. A. Marques (Coimbra, Portugal)
Source:
International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Session:
Healthcare, prevention and adjunctive treatments in respiratory infections
Session type:
Thematic Poster Session
Number:
2510
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Silva, R. Tomé, M. A. Marques (Coimbra, Portugal). Pulmonary fungal infection in immunocompetent vs immunocompromised patients - a retrospective study. Eur Respir J 2014; 44: Suppl. 58, 2510
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Prevalence of nontuberculosis mycobacterial in patients with bronchiectasis: A meta-analysis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014
Clinical characteristics of chronic pulmonary aspergillosis and colonization; retrospective analysis of patients with isolation of asperguillus species from respiratory samples
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Opportunistic infections in patients with lung tuberculosis
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Workshop 4 - Respiratory infections in immunocompromised children
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Nontuberculous mycobacteria and aspergillus coexistence in pulmonary disease – Retrospective analysis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Characteristics of nontuberculous mycobacterium pulmonary infection
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Clinical pattern of LRTI with RSV and hMPV in immunocompromised patients
Source: Annual Congress 2013 –Viral infections
Year: 2013
Respiratory infections in the immunocompromised host
Source: ERS Course 2018 - Respiratory Infections
Year: 2018
Clinical characteristics of pulmonary nocardiosis in immunocompetent patients
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation
Year: 2015
High prevalence of resistant bacterial infections in patients with tracheostomy due to neuromuscular disease (NMD)
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Cavitary bacterial lung infections – Predictive factors and outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Community adquired
legionella pneumophila
pneumonia in elderly patients
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Respiratory viral infections in community-acquired pneumonia and exacerbation of COPD: One year survey at a Japanese university hospital
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Respiratory infections in the immunocompromised host: from HIV to transplanted patient
Source: Annual Congress 2007 - Infections year in review
Year: 2007
The outcome of community-acquired pneumonia in patients with COPD, asthma and ILD - a case-control study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Characteristics of pulmonary MAC disease diagnosed later in follow-up after negative mycobacterial cultures by bronchoscopy
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Respiratory viral infection in immunocompromised patients
Source: International Congress 2018 – Clinical challenges in respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept